Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation Is Well Tolerated, Induces Anti-Tumor Immunity and May Lead to Eradication of Measureable Disease

Jacalyn Rosenblatt(Beth Israel Deaconess Medical Center), David Avigan(Beth Israel Deaconess Medical Center), Aya Sato-DiLorenzo(Beth Israel Deaconess Medical Center), Poorvi Somaiya(Beth Israel Deaconess Medical Center), Jon Arnason(Beth Israel Deaconess Medical Center), Robin Joyce(Beth Israel Deaconess Medical Center), Kenneth C. Anderson(Dana-Farber Cancer Institute), Lynne Uhl(Hadassah Medical Center), Paul G. Richardson(Harvard University), Nikhil C. Munshi(Dana-Farber Cancer Institute), Maxwell Coll, Jacob P. Laubach(Harvard University), Arnon Nagler(Sheba Medical Center), Katarina Luptakova(Tesaro (United States)), Donald Küfe(Dana-Farber Cancer Institute), Malgorzata McMasters(Beth Israel Deaconess Medical Center), Jacob M. Rowe(Technion – Israel Institute of Technology), Mary Paty Bryant(Beth Israel Deaconess Medical Center), Noam Binyamini(Rambam Health Care Campus), Irit Avivi(Tel Aviv Sourasky Medical Center), Salvia Jain(Broad Institute), Emma Logan(Beth Israel Deaconess Medical Center), Lina Bisharat(Beth Israel Deaconess Medical Center), Dina Stroopinsky(Beth Israel Deaconess Medical Center), Tami Katz(Beth Israel Deaconess Medical Center), James D. Levine(Beth Israel Deaconess Medical Center), Viki Held(Beth Israel Deaconess Medical Center), Kristen Palmer(Beth Israel Deaconess Medical Center), Merav Leiba(Ben-Gurion University of the Negev)

Blood

December 3, 2015

Cited by 12

|Nature|2013|10.1k

|New England Journal of Medicine|2017|6k

|New England Journal of Medicine|2003|2.6k

|Leukemia|2006|2.6k

|Journal of Clinical Oncology|2015|2.2k

Related Papers